リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Family with sequence similarity 20 member B regulates osteogenic differentiation of bone marrow mesenchymal stem cells on titanium surfaces」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Family with sequence similarity 20 member B regulates osteogenic differentiation of bone marrow mesenchymal stem cells on titanium surfaces

宋, 昕蔓 名古屋大学

2023.08.02

概要

主論文の要旨

Family with sequence similarity 20 member B regulates
osteogenic differentiation of bone marrow mesenchymal
stem cells on titanium surfaces
Family with sequence similarity 20 member B は
チタン表⾯における⾻髄由来間葉系幹細胞の
⾻分化能を制御する

名古屋大学大学院医学系研究科
頭頸部・感覚器外科学講座
(指導:日比 英晴
宋 昕蔓

総合医学専攻

顎顔面外科学分野
教授)

【Introduction】
Successful bone regeneration on titanium (Ti) surfaces is a key process in dental implant
treatment. Bone marrow mesenchymal stem cells (BMSCs) are fundamental cellular
components of this process, and their early recruitment, proliferation, and differentiation into
bone-forming osteoblasts are crucial. A proteoglycan (PG)-rich layer has been reported to exist
between Ti surfaces and bones; however, the molecules that could potentially affect the
formation of this layer remain unknown.
Family with sequence similarity 20 member B (FAM20B) is a newly identified kinase that
regulates the synthesis of glycosaminoglycans, an important component of the PG-rich layer.
And FAM20B is also closely associated with bone development.
The extracellular-regulated kinase (ERK1/2) pathway is important for maintaining bone
homeostasis, and has been reported to control osteogenic differentiation in response to
fibroblast growth factor 2 (FGF2) in BMSCs and affect the expression of osteoblast markers.
However, the effect of FAM20B on ERK1/2 signaling in BMSCs has not yet been reported.
Runt-related transcription factor 2 (RUNX2) is the main transcription factor for osteogenesis.
It contains a DNA-binding runt domain and plays a major role in the commitment of MSCs to
the osteoblastic lineage, regulating osteogenic differentiation and activating the expression of
genes related to osteogenesis.
We believe that FAM20B affects the osteogenic differentiation of BMSCs via ERK1/2 and
RUNX2. To test this hypothesis, we analyzed the function of FAM20B in BMSCs on Ti
surfaces.
【Materials and Methods】
The FAM20B knock down BMSCs cell lines (shBMSCs) were employed and all of cells
were cultured on Ti surfaces. The cells were then subjected to cell initial adhesion and
osteogenic differentiation. qRT-PCR, western blot, immunofluorescence, ALP activate assay,
reporter assay were used to explore the osteogenic-related target molecule expressions and
signaling pathway. Alizarin red staining was used to evaluate calcified nodules. The
transmission electron microscopy was also performed to analyze interface between Ti and
BMSCs.
【Results】
Topology of Ti surface
The morphology of the treated Ti surfaces (machined surfaces with ridges and valleys along
the treating direction) were clean and devoid of any contamination.
Establishing FAM20B knockdown cell lines
To investigate the role of FAM20B in osteogenesis, we obtained stable UE7T-13 cell lines

wherein FAM20B was knocked down. Two shRNA sequences and one control were separately
inserted into the UE7T-13 cell line using a lentivirus system. Furthermore, the cell proliferation
tests revealed that the depletion of FAM20B increased cell proliferation after the cells were
cultured on Ti surfaces for 48 h.
Effect of FAM20B on focal adhesion and PG-rich layer of BMSCs cultured on Ti surfaces
Quantification of the vinculin was done 1, 2, and 24 h after culturing the cells on Ti surfaces,
it can be observed that sh groups showed no significant difference in the area of expression of
vinculin from the control group at any time. After 14 days of culture, the area of the PG-rich
layer on the interface was observed to be lower in the sh groups than in the control group.
Effect of FAM20B on osteogenic differentiation of BMSCs cultured on Ti surfaces
The cells were cultured on Ti surfaces for seven days. Expression of osteogenic biomarkers
ALP and OCN were downregulated in sh groups. However, the expression of RUNX2 did not
show a difference in all groups. ALP staining was lighter in the sh groups. Similarly, ALP
activity also decreased in the sh groups after culturing on Ti surfaces for seven days. And lower
calcified nodules were observed in sh groups.
Effect of FAM20B on activation of ERK1/2 signaling of BMSCs cultured on Ti surfaces
pERK1/2 expression levels in the sh groups were lower than that in the control group while
maintaining the values for total ERK1/2.

In comparison to no FGF2 administration, FGF2

treatment promoted ALP expression in all groups, but the level of enhancement was higher in
the control group than in the sh group. Treatment with FGF2 increased the OCN expression in
the control group but not in the sh groups.
Effect of FAM20B on RUNX2 nuclear translocation
IF tests showed that while majority of the RUNX2 was in the nucleus for the control group,
it was in the cytosol for the sh groups when the cells were cultured on Ti surfaces for 24 h and
72 h. Likewise, the results of western blotting tests showed that the sh groups exhibited
decreased RUNX2 in the nucleus and increased RUNX2 in the cytosol when the cells were
cultured on Ti surfaces for 24 h and 72 h, but their total RUNX2 amount was similar to that of
the control group.
Effect of FAM20B on RUNX2 transcriptional activity
Transcriptional activity decreased in FAM20B siRNA groups compared to the control group.
And we found that the RUNX2-promoted activation of the OCN promoter was significantly
decreased by depletion of FAM20B.

【Discussion】
In this study, we established BMSC cell lines devoid of FAM20B and analyzed their function
in the osteogenic differentiation of BMSCs on Ti surfaces. After culturing for 14 days on Ti
surfaces, a reduced PG-rich layer was observed between the cells and the surfaces, which was
probably because of the incomplete formation of GAGs as a result of FAM20B depletion.
We also found that FAM20B depletion (a) resulted in decreased expression of osteogenesisrelated factors, (b) decreased ALP formation capacity and activity, and (c) reduced mineralization
ability in BMSCs cultured on Ti surfaces. These results suggest that FAM20B is an essential
component for osteogenic differentiation of BMSCs cultured on Ti surfaces.
In addition, depletion of FAM20B resulted in a reduced molecular level of pERK after FGF2
treatment. This further suggests that depletion of FAM20B inhibits the activation of the
ERK1/2 signaling pathway. In the present study, depletion of FAM20B was observed to inhibit
the osteogenic differentiation of BMSCs cultured on Ti surfaces, even though the expression
of RUNX2 remained unchanged. As a mechanism, the results of IF and Western blotting
showed that depletion of FAM20B in BMSCs inhibited nuclear translocation of RUNX2 and
reduced its transcriptional activity. Regarding the relationship between ERK activation and
RUNX2, ERK has been reported to not affect gene expression but stimulate transcriptional
activity. FAM20B was observed to reduce pERK1/2 signaling; this may have directly led to a
decrease in transcriptional activity.
To summarize, in this study, a part of the mechanism of bone formation on Ti surfaces has
been elucidated, which is the primary focus of dental implant treatment. Further research on
FAM20B is required for discovering a drug that will ensure successful dental implant treatment.
【Conclusion】
This study showed that FAM20B affected the osteogenic differentiation of BMSCs on Ti
surfaces through ERK1/2 and RUNX2 transcriptional activity.

この論文で使われている画像

参考文献

[1] X. Wang, F.A. Shah, F. Vazirisani, A. Johansson, A. Palmquist, O. Omar, K. Ekstrom, P. Thomsen,

Exosomes influence the behavior of human mesenchymal stem cells on titanium surfaces,

Biomaterials 230 (2020) 119571.

[2] J. Cui, L. Xia, K. Lin, X. Wang, In situ construction of a nano-structured akermanite coating for

promoting bone formation and osseointegration of Ti-6Al-4V implants in a rabbit osteoporosis model, J

Mater Chem B 9(46) (2021) 9505-9513.

[3] K.M. Hotchkiss, N.M. Clark, R. Olivares-Navarrete, Macrophage response to hydrophilic

biomaterials regulates MSC recruitment and T-helper cell populations, Biomaterials 182 (2018) 202215.

[4] L. Linder, T. Albrektsson, P.I. Branemark, H.A. Hansson, B. Ivarsson, U. Jonsson, I. Lundstrom,

Electron microscopic analysis of the bone-titanium interface, Acta Orthop Scand 54(1) (1983) 45-52.

[5] H. Nakamura, J. Shim, F. Butz, H. Aita, V. Gupta, T. Ogawa, Glycosaminoglycan degradation

reduces mineralized tissue-titanium interfacial strength, J Biomed Mater Res A 77(3) (2006) 478-86.

[6] K. Prydz, K.T. Dalen, Synthesis and sorting of proteoglycans, Journal of Cell Science 113(2) (2000)

193-205.

[7] S. Sarrazin, W.C. Lamanna, J.D. Esko, Heparan sulfate proteoglycans, Cold Spring Harb Perspect

Biol 3(7) (2011).

[8] H. Kamio, S. Tsuchiya, K. Kuroda, M. Okido, K. Okabe, Y. Ohta, N. Toyama, H. Hibi, Chondroitin-4sulfate transferase-1 depletion inhibits formation of a proteoglycan-rich layer and alters

immunotolerance of bone marrow mesenchymal stem cells on titanium oxide surfaces, Acta Biomater

114 (2020) 460-470.

[9] J. Wen, J. Xiao, M. Rahdar, B.P. Choudhury, J. Cui, G.S. Taylor, J.D. Esko, J.E. Dixon, Xylose

phosphorylation functions as a molecular switch to regulate proteoglycan biosynthesis, Proc Natl Acad

Sci U S A 111(44) (2014) 15723-8.

[10] X. Liu, N. Li, H. Zhang, J. Liu, N. Zhou, C. Ran, X. Chen, Y. Lu, X. Wang, C. Qin, J. Xiao, C. Liu,

Inactivation of Fam20b in the neural crest-derived mesenchyme of mouse causes multiple craniofacial

defects, Eur J Oral Sci 126(5) (2018) 433-436.

[11] P. Ma, W. Yan, Y. Tian, J. Wang, J.Q. Feng, C. Qin, Y.S. Cheng, X. Wang, Inactivation of Fam20B

in Joint Cartilage Leads to Chondrosarcoma and Postnatal Ossification Defects, Sci Rep 6 (2016)

29814.

[12] C. Bui, C. Huber, B. Tuysuz, Y. Alanay, C. Bole-Feysot, J.G. Leroy, G. Mortier, P. Nitschke, A.

Munnich, V. Cormier-Daire, XYLT1 mutations in Desbuquois dysplasia type 2, Am J Hum Genet 94(3)

(2014) 405-14.

[13] Y. Kuroda, H. Murakami, Y. Enomoto, Y. Tsurusaki, K. Takahashi, K. Mitsuzuka, H. Ishimoto, G.

Nishimura, K. Kurosawa, A novel gene (FAM20B encoding glycosaminoglycan xylosylkinase) for

neonatal short limb dysplasia resembling Desbuquois dysplasia, Clin Genet 95(6) (2019) 713-717.

[14] K. Hanada, J.E. Dennis, A.I. Caplan, Stimulatory Effects of Basic Fibroblast Growth Factor and

Bone Morphogenetic Protein-2 on Osteogenic Differentiation of Rat Bone Marrow-Derived

Mesenchymal Stem Cells, Journal of Bone and Mineral Research 12(10) (1997) 1606-1614.

[15] F. Gori, T. Thomas, K.C. Hicok, T.C. Spelsberg, B.L. Riggs, Differentiation of Human Marrow

19

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

33

34

35

36

37

38

39

40

41

42

Stromal Precursor Cells: Bone Morphogenetic Protein-2 Increases OSF2/CBFA1, Enhances

Osteoblast Commitment, and Inhibits Late Adipocyte Maturation, Journal of Bone and Mineral

Research 14(9) (1999) 1522-1535.

[16] S.L. Etheridge, G.J. Spencer, D.J. Heath, P.G. Genever, Expression Profiling and Functional

Analysis of Wnt Signaling Mechanisms in Mesenchymal Stem Cells, Stem Cells 22(5) (2004) 849-860.

[17] T. Gaur, C.J. Lengner, H. Hovhannisyan, R.A. Bhat, P.V. Bodine, B.S. Komm, A. Javed, A.J. van

Wijnen, J.L. Stein, G.S. Stein, J.B. Lian, Canonical WNT signaling promotes osteogenesis by directly

stimulating Runx2 gene expression, J Biol Chem 280(39) (2005) 33132-40.

[18] A.M. Osyczka, P.S. Leboy, Bone Morphogenetic Protein Regulation of Early Osteoblast Genes in

Human Marrow Stromal Cells Is Mediated by Extracellular Signal-Regulated Kinase and

Phosphatidylinositol 3-Kinase Signaling, Endocrinology 146(8) (2005) 3428-3437.

[19] H. Miraoui, K. Oudina, H. Petite, Y. Tanimoto, K. Moriyama, P.J. Marie, Fibroblast growth factor

receptor 2 promotes osteogenic differentiation in mesenchymal cells via ERK1/2 and protein kinase C

signaling, J Biol Chem 284(8) (2009) 4897-904.

[20] J. Zhang, W. Zhang, J. Dai, X. Wang, S.G. Shen, Overexpression of Dlx2 enhances osteogenic

differentiation of BMSCs and MC3T3-E1 cells via direct upregulation of Osteocalcin and Alp, Int J Oral

Sci 11(2) (2019) 12.

[21] G. Karsenty, Role of Cbfa1 in osteoblast differentiation and function, Semin Cell Dev Biol 11(4)

(2000) 301-8.

[22] H.J. Kim, M.H. Lee, H.S. Park, M.H. Park, S.W. Lee, S.Y. Kim, J.Y. Choi, H.I. Shin, H.J. Kim, H.M.

Ryoo, Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial

suture closure, Dev Dyn 227(3) (2003) 335-46.

[23] W. Saiyin, L. Li, H. Zhang, Y. Lu, C. Qin, Inactivation of FAM20B causes cell fate changes in

annulus fibrosus of mouse intervertebral disc and disc defects via the alterations of TGF-beta and

MAPK signaling pathways, Biochim Biophys Acta Mol Basis Dis 1865(12) (2019) 165555.

[24] Y. Tian, P. Ma, C. Liu, X. Yang, D.M. Crawford, W. Yan, D. Bai, C. Qin, X. Wang, Inactivation of

Fam20B in the dental epithelium of mice leads to supernumerary incisors, Eur J Oral Sci 123(6)

(2015) 396-402.

[25] T. Komori, Runx2, a multifunctional transcription factor in skeletal development, J Cell Biochem

87(1) (2002) 1-8.

[26] T. Komori, Regulation of skeletal development by the Runx family of transcription factors, J Cell

Biochem 95(3) (2005) 445-53.

[27] F. Long, Building strong bones: molecular regulation of the osteoblast lineage, Nat Rev Mol Cell

Biol 13(1) (2011) 27-38.

[28] S. Vimalraj, B. Arumugam, P.J. Miranda, N. Selvamurugan, Runx2: Structure, function, and

phosphorylation in osteoblast differentiation, Int J Biol Macromol 78 (2015) 202-8.

[29] I. Tosa, D. Yamada, M. Yasumatsu, E. Hinoi, M. Ono, T. Oohashi, T. Kuboki, T. Takarada,

Postnatal Runx2 deletion leads to low bone mass and adipocyte accumulation in mice bone tissues,

Biochem Biophys Res Commun 516(4) (2019) 1229-1233.

[30] M M Klinger, F Rahemtulla, C W Prince, L C Lucas, J E Lemons Crit Rev Oral Biol Med 9(4)

(1998) 449-63.

[31] L. Sun, G. Hong, H. Matsui, Y.J. Song, K. Sasaki, The Effects of Syndecan on Osteoblastic Cell

20

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

31

32

Adhesion Onto Nano-Zirconia Surface, Int J Nanomedicine 15 (2020) 5061-5072.

[32] X. Wang, K. Harimoto, S. Xie, H. Cheng, J. Liu, Z. Wang, Matrix Protein Biglycan Induces

Osteoblast Differentiation through Extracellular Signal-Regulated Kinase and Smad Pathways,

Biological and Pharmaceutical Bulletin 33(11) (2010) 1891-1897.

[33] S. Guimond, M. Maccarana, B.B. Olwin, U. Lindahl, A.C. Rapraeger, Activating and inhibitory

heparin sequences for FGF-2 (basic FGF). Distinct requirements for FGF-1, FGF-2, and FGF-4,

Journal of Biological Chemistry 268(32) (1993) 23906-23914.

[34] J. Chen, T. Sun, Y. You, B. Wu, X. Wang, J. Wu, Proteoglycans and Glycosaminoglycans in Stem

Cell Homeostasis and Bone Tissue Regeneration, Front Cell Dev Biol 9 (2021) 760532.

[35] L. Ling, C. Dombrowski, K.M. Foong, L.M. Haupt, G.S. Stein, V. Nurcombe, A.J. van Wijnen, S.M.

Cool, Synergism between Wnt3a and heparin enhances osteogenesis via a phosphoinositide 3kinase/Akt/RUNX2 pathway, J Biol Chem 285(34) (2010) 26233-44.

[36] S. Kim, T. Koga, M. Isobe, B.E. Kern, T. Yokochi, Y.E. Chin, G. Karsenty, T. Taniguchi, H.

Takayanagi, Stat1 functions as a cytoplasmic attenuator of Runx2 in the transcriptional program of

osteoblast differentiation, Genes Dev 17(16) (2003) 1979-91.

[37] M.S. Douglas, S. Ali, D.A. Rix, J.G. Zhang, J.A. Kirby, Endothelial production of MCP-1:

modulation by heparin and consequences for mononuclear cell activation, Immunology 92(4) (1997)

512-8.

[38] G. Xiao, D. Jiang, R. Gopalakrishnan, R.T. Franceschi, Fibroblast growth factor 2 induction of the

osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor,

Cbfa1/Runx2, J Biol Chem 277(39) (2002) 36181-7.

[39] C. Ge, G. Xiao, D. Jiang, Q. Yang, N.E. Hatch, H. Roca, R.T. Franceschi, Identification and

functional characterization of ERK/MAPK phosphorylation sites in the Runx2 transcription factor, J Biol

Chem 284(47) (2009) 32533-43.

[40] O.J. Park, H.J. Kim, K.M. Woo, J.H. Baek, H.M. Ryoo, FGF2-activated ERK mitogen-activated

protein kinase enhances Runx2 acetylation and stabilization, J Biol Chem 285(6) (2010) 3568-3574.

[41] Y. Qin, R. Sun, C. Wu, L. Wang, C. Zhang, Exosome: A Novel Approach to Stimulate Bone

Regeneration through Regulation of Osteogenesis and Angiogenesis, Int J Mol Sci 17(5) (2016).

[42] X.M. van Wijk, T.H. van Kuppevelt, Heparan sulfate in angiogenesis: a target for therapy,

Angiogenesis 17(3) (2014) 443-62.

[43] C.J. Percival, J.T. Richtsmeier, Angiogenesis and intramembranous osteogenesis, Dev Dyn

242(8) (2013) 909-22.

33

34

21

Table 1. Primer sequences for plasmids used in this study.

Plasmids

Sequence of oligomers

F: TGGAATTCTGCAGATATCCACCATGGCATCAAACAGC

pcDNA3.1-RUNX2-HA

R: GTATGGGTATCTCGAGCAATATGGTCGCCAAACAGATTC

F: GCTCGCTAGCCTCGAGCCTTTCCAGCCTTAATCTGTGACG

pNL1.2-OCN-promoter

R: CCGGATTGCCAAGCTTATGGTGTCTGCTAGGTCTGGG

F: GATCTAGCTGCAATCACCAACCACAGCATGR:

pNL3.2-6xOSE2-minP

R: GATCCATGCTGTGGTTGGTGATTGCAGCTA

F: AGATCCAGTTTATCGATGGCCTAACTGGCCGGTACC

pLVX-puro-6xORE2-minP

R: TAGAGTCGCGGGATCCTTTACCACATTTGTAGAGG

Table 2. Primer sequences for q-PCR.

Genes

Sequence (forward5’ – 3’)

Sequence (reverse3’ – 5’)

GAPD

AGCAAGAGCACAAGAGGAA

TCTACATGGCAACTGTGAG

FAM2

0B ALP

GAGGCTGTTGAGCACCTTCCTA

GAGATGTCTCCATCAGCACAAG

AC AGCTGAACAGGAACAACGT

ATTCTGCCTCCTTCCACCA

OCN

CACACTCCTCGCCCTATTG

CGCCTGGGTCTCTTCACTA

OSX

GAGGCAACTGGCTAGGTG

CTGGATTAAGGGGAGCAAA

Abbreviations:

osteocalcin; OSX, osterix.

G ALP, Alkaline phosphatase; OCN, GTC

Figure captions

Figure 1

(A) SEM images showing Ti surface characteristics after treatment at 100× and 1,000×

magnifications. (B) Elemental analysis of Ti surfaces. Abbreviations: C, carbon; N, nitrogen; O,

oxygen; F, fluorine; Al, aluminum; Si, silicon; Ti, titanium; V, vanadium; Cu, copper. (C)

Established FAM20B knockdown UE7T-13 cell lines. Changes in FAM20B mRNA expression

determined using RT-PCR. (D) FAM20B protein levels measured by western blot analysis. (E)

Immunofluorescence of FAM20B in Normal, Control and sh groups after culturing on Ti surfaces

for 24 h. Scale bar: 80 μm. (F) Cell proliferation of BMSCs on Ti surfaces. Three independent

10

experiments were performed, data are shown as the mean ± S.E. (*, p < 0.05, **, p < 0.01)

11

Figure 2

12

Focal adhesion and PG-rich layer formation in control and sh BMSCs on Ti surfaces. (A)

13

Immunofluorescence of vinculin (red) actin (green) and DAPI (blue) after 1 h, 2h, and 24 h. (B)

14

quantification of vinculin positive area. (C) Transmission electron micrographs of interface

15

between BMSCs and Ti surfaces; the PG-rich layer stained intensely with ruthenium red is

16

indicated by the black arrows. (D) Quantification of PG-rich layer area. PG-rich layer reduced in

17

sh groups. Scale bar: 600 nm. Three samples were prepared for each experimental group, and

18

fifteen images were analyzed for each experimental group. *p<0.05.

19

22

Figure 3

Osteogenic differentiation capacity of control and FAM20B shRNA BMSCs on Ti surfaces. (A)

Gene expression of the osteogenic biomarkers ALP, OCN, and RUNX2 of BMSCs on Ti surfaces.

(B) Gene expression of the osteogenic biomarkers ALP and OCN of BMSCs on Ti surfaces after

6 h of FGF2 stimulation. Three independent experiments were performed, data are shown as the

mean ± S.E. (*, p < 0.05, **, p < 0.01.)

Figure 4

ALP activity and mineralization capacity of control and FAM20B shRNA BMSCs on Ti surfaces.

(A) Representative images of ALP staining of BMSCs on Ti surfaces. (B) Quantitative analysis of

10

ALP activity assay. (C) Representative images of alizarin red S staining of BMSCs on Ti surfaces

11

and quantitative analysis of calcified nodules. Activation of ERK1/2 in control and FAM20B

12

shRNA BMSCs on Ti surfaces. (D) Protein levels of the pERK1/2 in BMSCs on Ti surfaces as

13

revealed by western blotting. (E) Quantification of signal intensities. Three independent

14

experiments were performed, data are shown as the mean ± S.E. (*, p < 0.05, **, p < 0.01)

15

Figure 5

16

RUNX2 nuclear localization in control and FAM20B shRNA BMSCs on Ti surfaces. (A, B)

17

Distribution of RUNX2 of BMSCs on Ti surfaces. Red is RUNX2 and blue is DAPI. (C, D) Western

18

blotting results showed RUNX2 expression in nuclear (N) extracts, cytosol (C) extracts, and total

19

proteins. TBP (TATA-binding protein) and a-tubulin as a loading control for nuclear and cytosolic

23

fractions. Three independent experiments were performed; data represented as mean ± S.E. (*, p

< 0.05, **, p < 0.01)

Figure 6

Transcriptional activity of RUNX2 in control and FAM20B siRNA HEK293 cell line. (A) Western

blotting results of FAM20B siRNA efficiency. (B) OSE2-dependent luciferase activity (C) OCN

promoter-dependent luciferase activity. Three independent experiments were performed, data are

shown as the mean ± S.E. (*, p < 0.05, **, p < 0.01)

10

24

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る